Biblio Discovery — Demo Discovery Service

19 hasil untuk "Nicholas J. Simmonds"

Menampilkan 1–19 · 0,48 detik · RSS

  1. Artikel Jurnal

    Cystic fibrosis modulator therapy can reverse cystic bronchiectasis

    Peter G. Middleton; Nicholas J. Simmonds

    Respirology Case Reports, Vol. 11 No. 7 · 2023 · Inggris · DOAJ Scopus

    Abstract Bronchiectasis is often considered progressive and irreversible, so cases of regression or reversal are an important step in understanding the underlying pathophysiological mechanisms. Cystic fibrosis, (CF) caused by pathogenic variants in the cystic fibrosis transmembrane conductance…

  2. Artikel Jurnal

    Beyond Cystic Fibrosis: Recognising Shwachman‐Diamond Syndrome in the Respiratory Clinic

    Freda Yang; Ladina Weitnauer; Imogen Felton dkk.

    Respirology Case Reports, Vol. 13 No. 12 · 2025 · Inggris · DOAJ Scopus

    ABSTRACT Cystic fibrosis (CF) and Shwachman‐Diamond Syndrome (SDS) share overlapping features, including recurrent respiratory infections and pancreatic insufficiency, which can complicate diagnosis. We report a case of a six‐year‐old girl who presented with productive cough, steatorrhea and…

  3. Artikel Jurnal

    Clinical characteristics and outcomes in adult cystic fibrosis patients with severe lung disease in Porto Alegre, southern Brazil

    Guilherme Figueiredo Silva; Nicholas J. Simmonds; Paulo de Tarso Roth Dalcin

    BMC Pulmonary Medicine, Vol. 20 No. 1 · 2020 · Inggris · DOAJ Scopus

    Abstract Background Advanced lung disease in adult cystic fibrosis (CF) drives most clinical care requirements. The aim was to evaluate outcome (time to death while in the study) in a cohort of adult CF patients with severe lung disease, and to determine the association among baseline patient…

  4. Artikel Jurnal

    Assessing the health risk of living near composting facilities on lung health, fungal and bacterial disease in cystic fibrosis: a UK CF Registry study

    Muhammad Saleem Khan; Philippa Douglas; Anna L. Hansell dkk.

    Environmental Health, Vol. 21 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Aim To explore the health risk of living near permitted composting sites (PCSs) on disease severity in children and adults with cystic fibrosis (CF) across the UK. Methods A semi-individual cross-sectional study was used to examine the risk of disease severity in people with CF (pwCF)…

  5. Artikel Jurnal

    Is daily physical activity affected by dynamic hyperinflation in adults with cystic fibrosis?

    Daniela Savi; Marcello Di Paolo; Nicholas J. Simmonds dkk.

    BMC Pulmonary Medicine, Vol. 18 No. 1 · 2018 · Inggris · DOAJ Scopus

    Abstract Background The aim of this study was to investigate the relationship between dynamic hyperinflation and daily physical activity (DPA) in adults with cystic fibrosis (CF). Methods Thirty-four clinically stable CF were studied. All patients undertook incremental cardiopulmonary exercise…

  6. Artikel Jurnal Teks lengkap

    Yoga Outcomes Get Assessed in Cystic Fibrosis (YOGA-CF): protocol of a multicentre interventional randomised controlled clinical trial—investigating effects of a 12-week yoga intervention for adults with cystic fibrosis

    Adam P Wagner; Nicholas J Simmonds; Susan C Charman dkk.

    BMJ Open Respiratory Research, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    Introduction Yoga is an emerging exercise choice for people with cystic fibrosis (CF), but evidence of its effect in this population is scarce, with a recent systematic review advocating for further research. Yoga Outcomes Get Assessed in CF (YOGA-CF) is a real-world multicentre randomised…

    Juga tersedia di: DOAJ

  7. Artikel Jurnal

    Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trial

    Gemma Stanford; Diana Bilton; Winston Banya dkk.

    BMJ Open Respiratory Research, Vol. 7 No. 1 · 2020 · Inggris · DOAJ Scopus

    Introduction Airway clearance techniques (ACTs) are a gold standard of cystic fibrosis management; however, the majority of research evidence for their efficacy is of low standard; often attributed to the lack of sensitivity from outcome measures (OMs) used historically. This randomised controlled…

  8. Artikel Jurnal

    Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review

    Gemma E. Stanford; Mandy Jones; Susan C. Charman dkk.

    Therapeutic Advances in Respiratory Disease, Vol. 16 · 2022 · Inggris · DOAJ Scopus

    Background: Airway clearance techniques (ACTs) are integral to cystic fibrosis (CF) management. However, there is no consensus as to which outcome measures (OMs) are best for assessing ACT efficacy. Objectives: To summarise OMs that have been assessed for their clinimetric properties (including…

  9. Artikel Jurnal

    complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case series

    Muttardi Kayria; Orchard Chris; Devesh J Dhasmana dkk.

    JRSM Open, Vol. 8 · 2017 · Inggris · DOAJ

    Lesson There is a high association of reactive skin presentations, mainly limited cutaneous vasculitis in patients with cystic fibrosis and Burkholderia cepcia complex chronic infection. This may be due to raised levels of circulating inflammatory mediators.

  10. Artikel Jurnal Teks lengkap

    Increased NFAT and NFκB signalling contribute to the hyperinflammatory phenotype in response to Aspergillus fumigatus in a mouse model of cystic fibrosis.

    Amelia Bercusson; Thomas J Williams; Nicholas J Simmonds dkk.

    PLoS Pathogens, Vol. 21 No. 2 · 2025 · Inggris · DOAJ Scopus

    Aspergillus fumigatus (Af) is a major mould pathogen found ubiquitously in the air. It commonly infects the airways of people with cystic fibrosis (CF) leading to Aspergillus bronchitis or allergic bronchopulmonary aspergillosis. Resident alveolar macrophages and recruited neutrophils are important…

    Juga tersedia di: PLOS

  11. Artikel Jurnal

    New strategies of physical activity assessment in cystic fibrosis: a pilot study

    Daniela Savi; Luigi Graziano; Barbara Giordani dkk.

    BMC Pulmonary Medicine, Vol. 20 No. 1 · 2020 · Inggris · DOAJ Scopus

    Abstract Background Regular physical activity (PA) is a valued part of cystic fibrosis (CF) care. Although the accelerometer, SenseWear Armband (SWA), accurately measures habitual PA in CF, it is mostly used for research purposes. For the first time, we analyzed different methods of measuring PA in…

  12. Artikel Jurnal

    Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures

    Silke van Koningsbruggen-Rietschel; Fiona Dunlevy; Veerle Bulteel dkk.

    Trials, Vol. 22 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract The SARS-CoV-2 pandemic has disrupted clinical trials worldwide. The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) has tracked clinical trial disruption by surveying its 58 trial sites across 17 European countries and collated information on measures to mitigate the…

  13. Artikel Jurnal

    Health State Utilities Associated With Treatment Burden in Cystic FibrosisTake-home Points

    Rory A. Cameron, PhD, MScPH; Jessie Matthews, MSc; Daniel Office, BSc dkk.

    CHEST Pulmonary, Vol. 3 No. 1 · 2025 · Inggris · DOAJ Scopus

    Background: Although recent advancements in the treatment of cystic fibrosis (CF) have improved survival, reducing high levels of treatment burden remains a priority issue for many people with cystic fibrosis (pwCF). However, economic evaluations of novel interventions may fail to capture their…

  14. Artikel Jurnal

    Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement project

    Andrew Jones; Francis Drobniewski; Michael Loebinger dkk.

    BMJ Open Quality, Vol. 14 No. 2 · 2025 · Inggris · DOAJ Scopus

    Aminoglycoside antibiotics cause ototoxicity for which baseline audiometric testing is recommended but often not done. Barriers to successful implementation include limited availability of sound-booths and audiologists. An ototoxicity monitoring programme (OMP) was implemented using tablet-based…

  15. Artikel Jurnal

    Managing an ageing cystic fibrosis population: challenges and priorities

    Freddy J. Frost; Daniel G. Peckham; Imogen C. Felton dkk.

    European Respiratory Review, Vol. 34 No. 176 · 2025 · Inggris · DOAJ Scopus

    The increasing life expectancy of people with cystic fibrosis (pwCF), largely driven by advancements in early diagnosis, multidisciplinary care and the recent introduction of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies, is likely to herald a shift in the focus of…

  16. Artikel Jurnal

    Genotype and transcript processing of the tumour necrosis factor receptor TNFRSF1A in epithelial cells: implications for survival in cystic fibrosisResearch in context

    Alexander Uden; Inga Dunsche; Sabina Janciauskiene dkk.

    EBioMedicine, Vol. 118 · 2025 · Inggris · DOAJ Scopus

    Summary: Background: Cystic fibrosis is caused by mutations of the cystic fibrosis transmembrane conductance regulator, CFTR, an epithelial anion transport protein, responsible for, inter alia, sputum viscoelasticity in the lung. We previously identified the TNF receptor superfamily 1A TNFRSF1A…

  17. Artikel Jurnal

    A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

    Eric WFW Alton; David K Armstrong; Deborah Ashby dkk.

    Efficacy and Mechanism Evaluation, Vol. 3 No. 5 · 2016 · Inggris · DOAJ

    Background: Cystic fibrosis (CF) is a chronic, life-limiting disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene leading to abnormal airway surface ion transport, chronic lung infections, inflammation and eventual respiratory failure. With the exception of the…